Optimization on the dose and time of nicaraven administration for mitigating the side effects of radiotherapy in a preclinical tumor-bearing mouse model.

Yong XuLina AbdelghanyReiko SekiyaDa ZhaiKeiichi JinguTao-Sheng Li

Published in: Therapeutic advances in respiratory disease (2022)

According to our data, the administration of nicaraven at a relatively low dose soon after radiotherapy will be recommended for attenuating the side effects of radiotherapy.

Keyphrases

early stage
low dose
locally advanced
mouse model
radiation induced
radiation therapy
squamous cell carcinoma
high dose
electronic health record
stem cells
bone marrow
mesenchymal stem cells
artificial intelligence